对多发性硬化症复发形式患者的迪罗西梅尔烟酸数据的分析,使用FDA不良反应报告系统的相关不良事件
Jing-Ya Yang1, Sheng-Zhu Sun1, Yi-Yan Sun2
1The First Clinical School, Shandong University of Traditional Chinese Medicine, Shandong, Jinan, China.
Expert opinion on drug safety
|April 2, 2025
概括
迪罗西梅尔烟酸 (DRF) 可能会导致新的不良事件,如免疫反应降低和复发性多发性硬化症 (RMS) 患者的暂时失明. 需要进一步的研究来确认这些潜在的风险.
科学领域:
- 药物监督 药物监督 药物监督
- 神经学 神经学
- 在瘤学瘤学.
背景情况:
- 迪罗西梅尔烟酸 (DRF) 是一种口服烟酸治疗复发性多发性硬化症 (RMS) 的治疗方法.
- 与DRF相关的不良事件 (AE) 需要持续进行全面分析.
- 美国食品和药物管理局的不良事件报告系统 (FAERS) 数据库是药物监测的关键资源.
研究的目的:
- 在复发性多发性硬化症 (RMS) 患者中全面分析与迪罗克西梅尔烟酸 (DRF) 相关的不良事件 (AEs).
- 识别 DRF 之前未记录的潜在的新安全信号.
- 在现实数据中使用可靠的统计方法来检测AE信号.
主要方法:
- 从FDA不良事件报告系统 (FAERS) 数据库 (2019-2024) 提取数据.
- 应用多种统计算法,包括报告几率比率 (ROR),比例报告比率 (PRR),贝叶斯信任传播神经网络 (BCPNN) 和多项马鱼缩小器 (MGPS) 进行信号检测.
- 分析了与DRF相关的7,868个AE报告,包括27个器官系统类别的120个首选术语.
主要成果:
- 鉴定了与DRF相关的几个临床上显著的潜在副作用.
- 值得注意的发现包括免疫反应降低 (ROR 4.45),女性乳腺癌 (ROR 4.07) 和暂时失明 (ROR 7.27).
- 这些信号表明,除了目前列出的DRF禁忌之外,还存在潜在的安全问题.
结论:
- 该研究确定了德罗西米尔烟酸 (DRF) 的潜在显著副作用,这些副作用在当前的产品信息中没有详细说明.
- 这些发现凸显了口服烟酸在RMS治疗中持续药物监测的重要性.
- 建议进行进一步的流行病学研究,以验证已识别的安全信号,并为临床实践提供信息.
相关概念视频
01:19Pharmacovigilance
755
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
755
01:25Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K